Northern Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
8,398
+143
+2% +$16.7K 0.71% 44
2026
Q1
$993K Buy
8,255
+3,574
+76% +$413K 0.72% 42
2025
Q4
$493K Sell
4,681
-2,744
-37% -$258K 0.56% 53
2025
Q3
$623K Sell
7,425
-462
-6% -$38.1K 0.33% 72
2025
Q2
$624K Sell
7,887
-699
-8% -$55.6K 0.47% 57
2025
Q1
$771K Sell
8,586
-6,007
-41% -$561K 0.64% 51
2024
Q4
$1.45M Sell
14,593
-5,450
-27% -$562K 1.16% 27
2024
Q3
$2.28M Sell
20,043
-1,861
-8% -$221K 1.73% 12
2024
Q2
$2.71M Buy
21,904
+464
+2% +$59.8K 2.17% 8
2024
Q1
$2.83M Buy
21,440
+334
+2% +$41.2K 2.21% 6
2023
Q4
$2.3M Buy
21,106
+801
+4% +$83.1K 1.94% 6
2023
Q3
$2.09M Buy
20,305
+4
+0% +$431 1.91% 7
2023
Q2
$2.34M Sell
20,301
-12
-0.1% -$1.36K 2.06% 6
2023
Q1
$2.16M Sell
20,313
-7
-0% -$756 2.03% 7
2022
Q4
$2.25M Buy
+20,320
New +$2.08M 2.55% 5

Other funds holding MRK

Northern Financial Advisors's MRK Position: Q2 2026 in Review

Northern Financial Advisors increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $16.7K and bringing the position to 8,398 shares worth $1.08M. The position accounts for 0.71% of the portfolio, ranked #44.

Northern Financial Advisors first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.83M in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Northern Financial Advisors held 8,398 shares of Merck worth $1.08M as of Q2 2026.
  • Northern Financial Advisors bought 143 Merck shares in Q2 2026, an estimated $16.7K.
  • Merck made up 0.71% of Northern Financial Advisors's portfolio in Q2 2026, its #44 holding.
  • Northern Financial Advisors first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Northern Financial Advisors's Merck position peaked at $2.83M in Q1 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Northern Financial Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.